PDGFRA and neoplasm: Intriguingly, enhanced benefit with hundred per cent tumor regression was observed in both PDGFRA amplified models which translates into elevated levels of activated PDGFRA receptors, either in combination with irinotecan in IGRM57 or irradiation in IGRG93.